Ovarian Sertoli Cell Tumor with Immature Prepubertal-like Sertoli Cell Component: A Case Report and Literature Review.


Journal

Medicina (Kaunas, Lithuania)
ISSN: 1648-9144
Titre abrégé: Medicina (Kaunas)
Pays: Switzerland
ID NLM: 9425208

Informations de publication

Date de publication:
13 Nov 2022
Historique:
received: 12 10 2022
revised: 02 11 2022
accepted: 10 11 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 29 11 2022
Statut: epublish

Résumé

The Sertoli cell tumor of the ovary is a rare ovarian tumor with non-specific symptoms. According to the literature, endocrine manifestations occur in two-thirds of patients, but testosterone production is extremely rare. Typically, it is a unilateral benign tumor of the ovary that most commonly presents in adolescents and young women of childbearing potential. We report a 29-year-old patient, previously diagnosed to have polycystic ovarian syndrome, who presented with complaints of amenorrhea for the past three years. A transvaginal ultrasound scan revealed polycystic structure ovaries and a solid cystic formation of 32 × 31 mm size with strong blood flow in the left ovary. The laboratory tests reported an elevated testosterone level. During laparoscopic surgery, a solid, yellowish tumor was removed and the left ovary was resected. Histological examination revealed a left ovary Sertoli cell tumor with an immature prepubertal-like Sertoli cell component. Following surgery, the serum testosterone levels returned to normal and the menstrual cycle became regular. Due to the substantially low incidence of ovarian Sertoli cell tumors, information on their clinical behavior, morphologic spectrum, optimal management, and prognosis is limited. They are characterized by a wide variety of clinical manifestations, treated surgically, and, if diagnosed at an early stage, have good prognosis. We emphasize the extraordinarily rare clinical presentation of this case report.

Identifiants

pubmed: 36422177
pii: medicina58111638
doi: 10.3390/medicina58111638
pmc: PMC9693394
pii:
doi:

Types de publication

Review Case Reports

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Surg Pathol. 2016 May;24(3):269-73
pubmed: 26621753
Surg Pathol Clin. 2019 Jun;12(2):587-620
pubmed: 31097116
Mod Pathol. 2005 Feb;18 Suppl 2:S81-98
pubmed: 15502809
J Pak Med Assoc. 2020 Jan;70(1):129-133
pubmed: 31954037
Ultrasound Obstet Gynecol. 2008 Jan;31(1):85-91
pubmed: 18098335
Am J Surg Pathol. 2005 Feb;29(2):143-56
pubmed: 15644771
Cancer. 1980 Nov 15;46(10):2281-97
pubmed: 7427869
Lancet Oncol. 2020 Jul;21(7):e360-e368
pubmed: 32615119
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv1-iv18
pubmed: 29697741
Abdom Radiol (NY). 2021 Apr;46(4):1519-1529
pubmed: 33725145

Auteurs

Diana Bužinskienė (D)

Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.
Center of Obstetrics and Gynecology, Institute of Clinical Medicine, Faculty of Medicine Vilnius University, LT-08661 Vilnius, Lithuania.

Evelina Šidlovska (E)

National Center of Pathology, Affiliate of Vilnius University Hospital Santaros Klinikos, LT- 08406 Vilnius, Lithuania.

Gabija Vilutytė (G)

Faculty of Medicine, Vilnius University, LT-03101 Vilnius, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH